Given that hexokinase II localizes to the PTP (100), from where it increases the use of glucose (101), p53 and hexokinase II may oppose each other in the control of tumor cell growth, as is indeed the case in castration-resistant prostate cancer (102). Here, TP53 is linked to neoplasm.